These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 6094778)
1. Seroepidemiologic behavior of varicella zoster virus infection in a semiclosed community after introduction of VZV vaccine. Baba K; Yabuuchi H; Takahashi M; Gershon AA; Ogra PL J Pediatr; 1984 Nov; 105(5):712-6. PubMed ID: 6094778 [TBL] [Abstract][Full Text] [Related]
2. A live varicella vaccine in a pediatric community. Yabuuchi H; Baba K; Tsuda N; Okada S; Nose O; Seino Y; Tomita K; Ha K; Mimaki T; Ogawa M Biken J; 1984 Sep; 27(2-3):43-9. PubMed ID: 6100057 [TBL] [Abstract][Full Text] [Related]
3. Live varicella vaccine in healthy individuals. Just M; Berger R; Luescher D Postgrad Med J; 1985; 61 Suppl 4():129-32. PubMed ID: 3014469 [TBL] [Abstract][Full Text] [Related]
4. Antibody response determined with antibody-dependent cell-mediated cytotoxicity (ADCC), neutralizing antibody, and varicella skin test in children with natural varicella and after varicella immunization. Ihara T; Kato T; Torigoe S; Oitani K; Isaji M; Ito M; Kamiya H; Sakura M Acta Paediatr Jpn; 1991 Feb; 33(1):43-9. PubMed ID: 1649540 [TBL] [Abstract][Full Text] [Related]
5. Increased incidence of herpes zoster in normal children infected with varicella zoster virus during infancy: community-based follow-up study. Baba K; Yabuuchi H; Takahashi M; Ogra PL J Pediatr; 1986 Mar; 108(3):372-7. PubMed ID: 3005536 [TBL] [Abstract][Full Text] [Related]
6. Viral replication and immunologic responses in children naturally infected with varicella-zoster virus and in varicella vaccine recipients. Asano Y; Itakura N; Hiroishi Y; Hirose S; Ozaki T; Kuno K; Nagai T; Yazaki T; Yamanishi K; Takahashi M J Infect Dis; 1985 Nov; 152(5):863-8. PubMed ID: 2995510 [TBL] [Abstract][Full Text] [Related]
7. Immunity to whole varicella-zoster virus antigen and glycoproteins I and p170: relation to the immunizing regimen of live attenuated varicella vaccine. Diaz PS; Smith S; Hunter E; Arvin AM J Infect Dis; 1988 Dec; 158(6):1245-52. PubMed ID: 2848901 [TBL] [Abstract][Full Text] [Related]
8. Persistence of cell-mediated and humoral immune responses in healthy children immunized with live attenuated varicella vaccine. Watson B; Gupta R; Randall T; Starr S J Infect Dis; 1994 Jan; 169(1):197-9. PubMed ID: 8277182 [TBL] [Abstract][Full Text] [Related]
9. Natural and artificial immunity to varicella zoster virus. Ndumbe PM; Cradock-Watson J; Levinsky RJ J Med Virol; 1988 Jun; 25(2):171-8. PubMed ID: 2839610 [TBL] [Abstract][Full Text] [Related]
10. Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany. Wiese-Posselt M; Siedler A; Mankertz A; Sauerbrei A; Hengel H; Wichmann O; Poethko-Müller C BMC Infect Dis; 2017 May; 17(1):356. PubMed ID: 28525973 [TBL] [Abstract][Full Text] [Related]
11. Antibody response to varicella-zoster virus after natural or vaccine-induced infection. Bogger-Goren S; Baba K; Hurley P; Yabuuchi H; Takahashi M; Ogra PL J Infect Dis; 1982 Aug; 146(2):260-5. PubMed ID: 6286790 [TBL] [Abstract][Full Text] [Related]
12. Varicella vaccination in HIV-1-infected children after immune reconstitution. Bekker V; Westerlaken GH; Scherpbier H; Alders S; Zaaijer H; van Baarle D; Kuijpers T AIDS; 2006 Nov; 20(18):2321-9. PubMed ID: 17117018 [TBL] [Abstract][Full Text] [Related]
13. Immune response induced by live attenuated varicella vaccine and short term follow-up on immunity of the vaccinated children. Chiba Y; Miura J; Kumagai T; Nakao T Biken J; 1984 Sep; 27(2-3):67-71. PubMed ID: 6100061 [TBL] [Abstract][Full Text] [Related]
14. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection. Dennehy PH; Saracen CL; Peter G Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862 [TBL] [Abstract][Full Text] [Related]
15. Live attenuated varicella vaccine: protection in healthy adults compared with leukemic children. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group. Gershon AA; Steinberg SP J Infect Dis; 1990 Apr; 161(4):661-6. PubMed ID: 2156941 [TBL] [Abstract][Full Text] [Related]
16. A seroepidemiologic survey of the prevalence of varicella-zoster virus in the pediatric population in two university hospitals in Brazil. Semenovitch I; Lupi O Int J Dermatol; 2003 Mar; 42(3):193-6. PubMed ID: 12653913 [TBL] [Abstract][Full Text] [Related]
17. Immunity to varicella zoster virus in children with leukaemia. Ndumbe PM; Wheeler K; Chessells JM; Levinsky RJ Med Microbiol Immunol; 1988; 177(2):83-9. PubMed ID: 2834625 [TBL] [Abstract][Full Text] [Related]
18. Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses. Weinberg A; Lazar AA; Zerbe GO; Hayward AR; Chan IS; Vessey R; Silber JL; MacGregor RR; Chan K; Gershon AA; Levin MJ J Infect Dis; 2010 Apr; 201(7):1024-30. PubMed ID: 20170376 [TBL] [Abstract][Full Text] [Related]
19. Cell-mediated immune responses after immunization of healthy seronegative children with varicella vaccine: kinetics and specificity. Watson B; Keller PM; Ellis RW; Starr SE J Infect Dis; 1990 Oct; 162(4):794-9. PubMed ID: 2169495 [TBL] [Abstract][Full Text] [Related]
20. Long-term protective immunity of recipients of the OKA strain of live varicella vaccine. Asano Y; Nagai T; Miyata T; Yazaki T; Ito S; Yamanishi K; Takahashi M Pediatrics; 1985 Apr; 75(4):667-71. PubMed ID: 2984636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]